Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
84 participants
INTERVENTIONAL
2025-02-19
2027-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this research is to compare two brief interventions delivered by videoconference to learn if they help women effectively manage these changes and restore sexual health and functioning.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sexual Health and Rehabilitation After Ovarian Suppression Treatment
NCT03571841
eSense-Cancer: Adapting an Online Intervention for Sexual Health Concerns to Gynecologic Cancer
NCT06619769
Developing and Pre-Testing an eHealth Group Intervention for Young Adult Cancer Survivors
NCT05054569
Developing an Internet-Delivered Sexual Health Program for Breast Cancer Survivors, SHINE Trial
NCT06216574
Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer
NCT03902379
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants in this study would first complete health questionnaires and then be randomized to take part in one of two types of education sessions delivered by an instructor over videoconference: 1) Group education session or 2) Individual self-management session.
About 56 women will receive the group education session and about 28 will receive the individual self-management session.
It is expected that about 84 women will take part in this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SHAREonline
Participants will receive:
* One online group session structured around three 60-minute modules and creation of a personal action plan
* Single Coaching phone call at one month
* Questionnaires to complete at baseline, 2 and 4 Months
Group Session
On-line educational session-3 modules-1 hour each for a total of 3 hours
Coaching Call
Single Coaching phone call at one month
Individual Self Management
Brief individualized session with online and written materials and guidance.
All Participants will complete study questionnaires at baseline, 2 months and 4 months post intervention
Educational Materials
Individual videoconference session in which participants will receive a pdf of the American Cancer Society booklet, 'Sex and the Adult Female with Cancer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group Session
On-line educational session-3 modules-1 hour each for a total of 3 hours
Coaching Call
Single Coaching phone call at one month
Educational Materials
Individual videoconference session in which participants will receive a pdf of the American Cancer Society booklet, 'Sex and the Adult Female with Cancer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Any impairment (e.g., hearing, visual, cognitive) that interferes with the ability to complete all study procedures independently
19 Years
49 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Dana-Farber Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sharon Bober, Ph.D
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sharon Bober, PhD
Role: PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-697
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.